Berg-Johnsen J
Nevrokirurgisk avdeling, Kirurgisk klinikk, Ullevål sykehus, Oslo.
Tidsskr Nor Laegeforen. 1993 Feb 20;113(5):565-8.
Intravenous anaesthetic agents depress the activity of the brain by acting on receptor-operated ion channels. Barbiturates enhance gamma-aminobutyric acid (GABA)-mediated inhibition, depress glutamate-mediated excitation, and hyperpolarize the membrane by increased potassium conductance. Benzodiazepines facilitate GABA-mediated inhibition by binding to a benzodiazepine recognition site on the GABA receptor complex, and affect potassium channels. Opioids bind to opioid receptors and hyperpolarize the membrane by enhanced potassium and calcium conductances. Ketamine depresses excitatory synaptic transmission by acting on glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype. Propofol acts at a recognition site on the GABA receptor, which differs from the binding sites of both barbiturates and benzodiazepines.
静脉麻醉药通过作用于受体操纵的离子通道来抑制大脑活动。巴比妥类药物增强γ-氨基丁酸(GABA)介导的抑制作用,抑制谷氨酸介导的兴奋作用,并通过增加钾电导使膜超极化。苯二氮䓬类药物通过与GABA受体复合物上的苯二氮䓬识别位点结合来促进GABA介导的抑制作用,并影响钾通道。阿片类药物与阿片受体结合,并通过增强钾和钙电导使膜超极化。氯胺酮通过作用于N-甲基-D-天冬氨酸(NMDA)亚型的谷氨酸受体来抑制兴奋性突触传递。丙泊酚作用于GABA受体上的一个识别位点,该位点与巴比妥类药物和苯二氮䓬类药物的结合位点不同。